Differential stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor in extensive and poor metabolizers of pantoprazole?a preliminary study
Authors:
Abstract
Pantoprazole (PAN) is a proton pump inhibitor that is administered as a racemic mixture. The pharmacokinetics of PAN enantiomers were investigated in extensive metabolizers (EMs) and apparent poor metabolizers (PMs) of PAN who received a single 40, 60, or 80 mg oral dose of racemic PAN as enteric‐coated formulation. In the EMs, the serum concentrations of (−)‐PAN were slightly higher than those of (+)‐PAN at each dose level. The (+)/(−) ratios for the area under the concentration‐time curve (AUC) and the half‐life were 0.58–0.89 and 0.62–0.88, respectively. In the PMs, the serum concentrations of both enantiomers were much higher than those in the EMs at each dose level and significant differences in pharmacokinetics of (+)‐ and (−)‐PAN were observed. The half‐lives for (+)‐PAN were 2.67–3.77 times longer than those for (−)‐PAN. The AUCs for (+)‐PAN were 2.65–3.45 times greater than those for (−)‐PAN. Therefore, the metabolism of (+)‐PAN is impaired to a greater extent than (−)‐PAN in the PMs, which resulted in the stereoselective disposition of PAN in the PMs. It has been suggested that the EMs and the PMs of PAN could be differentiated by determining the (+)/(−) enantiomer ratio in serum at one time point, possibly 2–6 h after oral dosing, because the (+)/(−) enantiomer ratios in the PMs were opposite those in the EM subjects. Chirality 9:17–21, 1997Keywords
This publication has 9 references indexed in Scilit:
- Direct Determination of Pantoprazole Enantiomers in Human Serum by Reversed-Phase High-Performance Liquid Chromatography Using a Cellulose-Based Chiral Stationary Phase and Column-Switching System as a Sample Cleanup ProcedureAnalytical Chemistry, 1996
- Enantioselective high-performance liquid chromatographic determination of omeprazole in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjectsEuropean Journal of Clinical Pharmacology, 1993
- Omeprazole: A Comprehensive ReviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1993
- LansoprazoleDrugs, 1992
- Effect of repeated oral administration of BY 1023/SK&F 96022 – a new substituted benzimidazole derivative – on pentagastrin‐stimulated gastric acid secretion and pharmacokinetics in manAlimentary Pharmacology & Therapeutics, 1990
- Slow Omeprazole Metabolizers Are Also Poor S-Mephenytoin HydroxylatorsTherapeutic Drug Monitoring, 1990
- By 1023/SK&F 96022: Biochemistry of a novel (H+ + K+-ATPase inhibitorBiochemical Pharmacology, 1990
- Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazoleClinical Pharmacology & Therapeutics, 1990